Tech Company Financing Transactions

Clementia Pharmaceuticals Funding Round

Clementia Pharmaceuticals secured a $60 million funding round on 6/24/2015. Investors included New Enterprise Associates, BDC Venture Capital and EcoR1 Capital Management.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

4150 Ste-Catherine St. West 550
Montreal QC, H3Z 2Y5
Canada

Phone

(514) 940-3600

Website

www.clementiapharma.com

Email Address

Not Recorded

Overview

Clementia Pharmaceuticals is focused on developing palovarotene for fibrodysplasia ossificans progressiva (FOP) and other diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Clarissa Desjardins

        

Chief Financial Officer

Michael Singer

        

Chief Medical Officer

Donna Grogan

        

VP - Bus. Development

Jeffrey Packman

        

VP - Sales

Eric Grinstead

        

Browse more venture capital transactions:

Prev: 6/24/2015: Replicated venture capital transaction
Next: 6/24/2015: HackerOne venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on tech company VC transactions. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary